The generic ingredient in QINLOCK is ripretinib. Extra details are readily available on the ripretinib profile page.
For more details on how DrugPatentWatch can assist with your pharmaceutical service intelligence needs, contact admin@DrugPatentWatch.com or go to www.DrugPatentWatch.com
DrugPatentWatch. Originally released at
New patent for Deciphera Pharms drug QINLOCKAnnual Drug Patent Expirations for QINLOCK
This drug has twenty-seven patent household members in 10 countries.
Qinlock is a drug marketed by Deciphera Pharms and is consisted of in one NDA. There are 3 patents protecting this drug.
Make Better Decisions with DrugPatentWatch
Get the Daily Briefing or Try a trial
DrugPatentWatch. Originally published at
New patent for Deciphera Pharms drug QINLOCK